Skip to Main Content

Paper Details

Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.
Anticancer Res
6
2022
Author NameAffiliation
Lodewyk F A WesselsUniversity Medical Center Mannheim (UMM), University of Heidelberg
  • 1 - 1

Datasets

Release 1.2